首页> 外文期刊>International Journal of Pharmaceutics >Does carrier size matter? A fundamental study of drug aerosolisation from carrier based dry powder inhalation systems.
【24h】

Does carrier size matter? A fundamental study of drug aerosolisation from carrier based dry powder inhalation systems.

机译:载具大小重要吗?对基于载体的干粉吸入系统进行药物雾化的基础研究。

获取原文
获取原文并翻译 | 示例
       

摘要

There is plenty of evidence supporting the notion that the size of the carrier influences the aerosolisation performance of drug from a drug-carrier blend. Interestingly, that evidence is contradictory in places and the study of such mechanisms is fraught by the compounding variables associated with comparing crystalline powders (e.g. as size is varied so may the shape, surface chemistry, roughness and the amount of fine excipients). To overcome these limitations, a series of model polystyrene spheres were used to study the influence of size on aerosol performance. Three polystyrene sphere carriers (TS-80, TS-250 and TS-500, describing their approximate diameters) were characterised using laser diffraction, atomic force microscopy, colloid probe microscopy, electron microscopy, true density and dynamic vapour sorption. The model carriers were blended with micronized salbutamol sulphate (67.5:1 ratios) and the aerosolisation performance was tested using a multistage liquid impinger at a range of flow rates (40-100 lmin(-1)). Physico-chemical analysis of the carriers indicated that all carriers were spherical with similar roughness and densities. Furthermore, the adhesion force of drug to the carrier surfaces was independent of carrier size. Significant differences in drug aerosolisation were observed with both flow rate and carrier size. In general, as carrier size was increased, aerosol performance decreased. Furthermore, as flow rate was increased so did performance. Such observations suggest that higher energy processes drive aerosolisation, however this is likely to be due to the number of impaction events (and associated frictional and rotational forces) rather than the actual collision velocity (since the larger carriers had increased momentum and drag forces). This study shows that, in isolation of other variables, as carrier size increases, a concurrent decrease in drug aerosolisation performance is observed.
机译:有大量证据支持这样的观点,即载体的大小会影响来自药物-载体混合物的药物的雾化性能。有趣的是,这些证据在地方上是相互矛盾的,并且这种机理的研究充满了与比较结晶粉末有关的复合变量(例如,随着大小的变化,形状,表面化学性质,粗糙度和精细赋形剂的量也可能变化)。为了克服这些限制,使用了一系列模型聚苯乙烯球来研究尺寸对气溶胶性能的影响。使用激光衍射,原子力显微镜,胶体探针显微镜,电子显微镜,真密度和动态蒸气吸附对三种聚苯乙烯球载体(TS-80,TS-250和TS-500,描述了它们的近似直径)进行了表征。将模型载体与微粉化的硫酸沙丁胺醇混合(比例为67.5:1),并使用多级液体冲击器在一定范围的流速(40-100 lmin(-1))下测试雾化性能。载体的理化分析表明,所有载体均为球形,具有相似的粗糙度和密度。此外,药物对载体表面的粘附力与载体尺寸无关。流速和载体尺寸均观察到药物雾化的显着差异。通常,随着载体尺寸的增加,气雾剂性能下降。此外,随着流速的提高,性能也随之提高。这些观察结果表明,较高能级的过程推动了雾化,但是这很可能是由于撞击事件(以及相关的摩擦力和旋转力)的数量所致,而不是实际的碰撞速度(因为较大的载具具有增加的动量和阻力)。这项研究表明,除其他变量外,随着载体尺寸的增加,观察到药物雾化性能的同时下降。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号